ScreenerHero

ACARIX Acarix AB (publ)

STO · SE · Healthcare · Medical Devices · acarix.com
0.2210SEK+5.49%Mkt Cap: 26.22M $P/E: —

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and adva…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc. - Common Stock
$32.21BUSDP/E 33.7
GEHC
GE HealthCare Technologies Inc. - Common Stock
$29.24BUSDP/E 14.8
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
TXG
10x Genomics, Inc. - Common Stock
$12.18BUSD
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
GKOS
Glaukos Corporation
$9.67BUSD

Key Statistics

Company
Market Cap26.22M USD
Enterprise Value22.10M USD
Revenue (TTM)882.20K USD
Gross Profit596.68K USD
Net Income (TTM)-4.60M USD
Revenue/Share0.0080 SEK
Last Price0.2210 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-6.09
EV/Revenue25.05
P/S28.18
P/B5.99
EPS (TTM)-0.04
EPS (Forward)0.00
52W Range
0.180024% of range0.3490
52W High0.3490 SEK
52W Low0.1800 SEK
Profitability
Gross Margin84.74%
Oper. Margin-403.73%
EBITDA Margin0.00%
Profit Margin-653.32%
ROE-125.99%
ROA-99.51%
Growth
Revenue Growth102.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.57M USD
CapEx (TTM)72.41K USD
FCF Margin-260.23%
FCF Yield-8.75%
Net Debt-2.76M USD
Net Debt/EBITDA0.76
Balance Sheet
Debt/Equity—
Current Ratio10.67
Quick Ratio9.12
Book Value/Sh0.04 SEK
Cash/Share0.02 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.4000 SEK
Upside (mean)+81.0%
Target Range0.4000 SEK – 0.4000 SEK
# Analysts1
Ownership
Shares Out.1.24B
Float1.10B
Insiders10.87%
Institutions7.48%
Technical
SMA 500.2300 (-3.9%)
SMA 2000.2588 (-14.6%)
Beta-0.21
S&P 52W Chg14.58%
Avg Vol (30d)1.50M
Avg Vol (10d)1.54M
Technical Indicators
RSI (14)47.4
MACD-0.0084
MACD Signal-0.0099
MACD Hist.+0.0015
BB Upper0.2284 SEK
BB Middle0.2081 SEK
BB Lower0.1878 SEK
BB Width19.51%
ATR (14)0.0154 SEK
Vol Ratio (20d)0.87x